Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Aug 2026. Factsheet Jun 2026. About · Disclosures
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured
ICICI Prudential Mutual FundSectoral Pharma and HealthcareDirectGrowthVery high risk
NAV
₹46.95
As on 19 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +7.93% | — | — |
| 3 year | +22.86% | — | — |
| 5 year | +16.84% | — | — |
- Sharpe
- 1.21
- Std dev
- 16.87%
- Beta
- 0.97
All Sectoral Pharma and Healthcare funds · ICICI Prudential Mutual Fund
Returns
From NAVs through 19 Aug 2026
1Y
+7.93%
Total
3Y
+22.86%
p.a.
5Y
+16.84%
p.a.
SI
+16.95%
p.a.
Calendar years
-7.63%2022
+42.55%2023
+49.36%2024
+0.05%2025
+9.06%2026 YTD
Rolling 1-year · 51 overlapping windows
-11.23%avg +19.99%+65.10%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹6,624.58 Cr
Expense ratio
0.87%
Exit load
None
Lock-in
None
BenchmarkBSE Healthcare TRI
Launched11 Jul 2018
Risk levelVery high
StructureOpen Ended
ISININF109KC1GH2
Where the money is invested
Split by asset type.
By asset type
Equity99.82%
Cash0.18%
What the fund holds
45 holdings · portfolio as on 30 May 2026
- 12.09%Sun Pharmaceuticals Industries LtdHealthcare
- 7.7%Dr Reddy's Laboratories LtdHealthcare
- 7.45%Cipla LtdHealthcare
- 7.03%Mankind Pharma LtdHealthcare
- 6.06%Divi's Laboratories LtdHealthcare
- 5.18%Treps
- 4.71%Biocon LtdHealthcare
- 4.37%Cohance Lifesciences LtdHealthcare
- 4.08%Alkem Laboratories LtdHealthcare
- 3.86%Medplus Health Services LtdHealthcare
Concentration
Top 5 weight
40.33%
Top 10 weight
62.54%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
1.21
Better than category avg 0.98
Sortino
1.77
Return per unit of downside risk
Alpha
2.63
Return above the benchmark
Information ratio
0.31
Consistency of outperformance
Risk
Std deviation
16.87%
How much returns swing
Beta
0.97
Below category avg 0.95
R-squared
94.6%
How closely it tracks the benchmark
Who manages this fund
2 fund managers
- DKDharmesh Kakkad7.8 years in the industryRuns 13 schemes
- SASharmila Adrian Dsilva0.5 years in the industryRuns 53 schemes
Other Sectoral Pharma and Healthcare funds
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
Bajaj Finserv Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+22.86%
Invested
₹6,00,000
Illustrated
₹23,07,626
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured NAV today?
- The latest NAV of ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured is ₹46.95 as on 19 Aug 2026.
How has ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured performed vs its category?
- 1-year return +7.93%. Past performance does not guarantee future returns.
What are the returns of ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured?
- Trailing returns from published NAVs: 1 year +7.93%, 3 year +22.86% a year, 5 year +16.84% a year, since our first NAV +16.95% a year. Past performance does not guarantee future returns.
How would a SIP in ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +22.86%. It is not a forecast.
What is the expense ratio and fund size of ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured?
- For ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured, the expense ratio is 0.87% and fund size (AUM) is ₹6,624.58 Cr.
What is the ISIN of ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured?
- The ISIN for ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured is INF109KC1GH2.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.